See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-121. First Human Transcatheter Aortic Valve Implantation of the Colibri Heart Valve, A Pre-mounted, Pre-packaged, Low Profile Ready for Use, Dry Valve in a 14 French Deliver...

Presenter: David Paniagua

October 29, 2013

Presentation

Coronary Calcification: Insights from Angiography, IVUS, and OCT

Presenter: Gary Mintz

October 29, 2013

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Presentation TCT 2013

Aspirin Dead, Warfarin Still Alive

Presenter: Kristen Patton

October 29, 2013

Presentation TCT 2013

Patent Hemostasis: Taking It to the Next Level

Presenter: Samir Pancholy

October 28, 2013

Presentation TCT 2013

Position #2: Simple Telemonitoring is the Way to Go

Presenter: Matthew Maurer

October 28, 2013

Presentation TCT 2013

Patient Safety Days: A Health Care Systems Commitment

Presenter: Anthony Dawson

October 28, 2013

Advertisement

Slides

TCT-121. First Human Transcatheter Aortic Valve Implantation of the Colibri Heart Valve, A Pre-mounted, Pre-packaged, Low Profile Ready for Use, Dry Valve in a 14 French Deliver...

Coronary Calcification: Insights from Angiography, IVUS, and OCT

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Aspirin Dead, Warfarin Still Alive

Patent Hemostasis: Taking It to the Next Level

Position #2: Simple Telemonitoring is the Way to Go

Patient Safety Days: A Health Care Systems Commitment

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content